|Bid||0.1600 x 6775200|
|Ask||0.1650 x 5329900|
|Day's range||0.1600 - 0.1650|
|52-week range||0.0690 - 0.1900|
|Beta (5Y monthly)||0.70|
|PE ratio (TTM)||N/A|
|Earnings date||02 Mar 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||0.50|
Michael Johnson is the CEO of Rhinomed Limited ( ASX:RNO ), and in this article, we analyze the executive's...
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the Innovation Virtual lnvestor Conference are now available for on-demand viewing.